Jennifer Michaelson - 12 May 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Development Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
12 May 2023
Net transactions value
-$1,695
Form type
4
Filing time
16 May 2023, 17:36:55 UTC
Previous filing
20 Apr 2023
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale $1,695 -193 -0.21% $8.78 90,686 12 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.